Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Monogram Technologies Inc. Capital/Financing Update 2020

Mar 17, 2020

33540_rns_2020-03-17_a1877005-5199-424f-be4a-3b53f202dcbc.zip

Capital/Financing Update

Open in viewer

Opens in your device viewer

253G2 1 tm2013001-1_253g2.htm 253G2

Filed pursuant to Rule 253(g)(2)

File No. 024-10973

SUPPLEMENT DATED MARCH 17, 2020

OFFERING CIRCULAR DATED SEPTEMBER 20, 2019

MONOGRAM ORTHOPAEDICS, INC.

This document supplements, and should be read in conjunction with, the Offering Circular (the “Offering Circular”) dated September 20, 2019 of Monogram Orthopaedics, Inc. (the “Company”). Unless otherwise defined in this supplement, capitalized terms used in this supplement shall have the same meanings as set forth in the Offering Circular.

The purpose of this supplement is to

· Announce the Company’s intention to terminate the offering described in the Offering Circular on April 24, 2020, as qualified by reference to the description of the Company’s intentions below.

Offering Termination Date

The Company intends to terminate the offering for its Series A Preferred Stock described in the Offering Circular. No further subscriptions will be accepted for the current offering after April 24, 2020 (the “Termination Date”). Subscriptions in the offering will be accepted up to that date and processed as promptly as possible. None of the terms of the offering have been changed. In addition, as described in the Offering Circular, the Company retains the right to continue the offering beyond the Termination Date, in its sole discretion.

Field: Page; Sequence: 1; Options: Last

Field: /Page